Neurodegenerative diseases are disorders that are related and affect the neurons in the human brain. Since, the neurons don’t reproduce like the rest of the human body cells; it results in a condition which is incurable, leading to mental functioning problems. The global neurodegenerative disease market is expected to grow meaningfully, growing at a CAGR of 4.90% in the forecast period.

The market for neurodegenerative disease is segmented into movement disorders, progressive dementia, and dementia with some other neurological disorders. The market for progressive dementia holds the largest market share of the global neurodegenerative diseases market, which is followed by market for dementia of other neurological disorders. On the basis of drug type the market for neurodegenerative diseases is categorized into SSRIs, NMDA and Dopamine Inhibitors. On the basis of indication, the market is divided into Parkinson’s disease, Amyotrophic disease,  Alzheimer’s disease, and Huntington disease.

Since the nature of the neurodegenerative diseases is complex, there are many factors that prompt the growth of the global neurodegenerative disease market; some of the key forces include the rapid growth of the neurodegenerative diseases across the globe and growing awareness about the mental disorders. The growing geriatric population across the world increase the chances of occurrence of neurological diseases. The constant researches that are carried on to find an effective treatment for these neurodegenerative diseases also fuel the hope for the growth of this market.

The major restraining factors of the global neurodegenerative disease market are the lack of effective drugs and therapies to treat the disease. Also, the lack of information about the causes of these neurodegenerative diseases hinders the development of drugs and treatment for the same.

The global market for neurodegenerative diseases is geographically segmented into North America, Europe, Asia Pacific and Rest of the world. Asia pacific is projected to grow at a higher pace owing to the growing population and increasing awareness among the people about the neurological disorders.

The key market players for the global neurodegenerative disease market are Pfizer, Abbott Laboratories, Colucid Pharmaceuticals Ltd, Baxter Internationals Inc., UCB, Biogen Idec, Roche Holdings Ltd, Novartis, Cipla Ltd, Daiichai Sankyo Co. Ltd, Teva Pharmaceutical Industry, Merck Serono, Neuro-Hitech Inc., and more.

Request for Sample